Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roly Gosling

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Malaria Journal|December 8, 2021
Civilian-military malaria outbreak response in Thailand: an example of multi-stakeholder engagement for malaria eliminationMichelle E Roh, Kanyarat Lausatianragit, Nithinart Chaitaveep, et al.
Frontiers in Genetics|April 26, 2021
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical TrialsNuno Sepúlveda, Lynn Grignard, Jonathan Curry, et al.
Nucleic Acids Research|May 23, 2019
FLASH: a next-generation CRISPR diagnostic for multiplexed detection of antimicrobial resistance sequencesJenai Quan, Charles Langelier, Alison Kuchta, et al.
Lancet (London, England)|April 27, 2020
Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trialMichelle S Hsiang, Henry Ntuku, Kathryn W Roberts, et al.
The Lancet. Infectious Diseases|January 12, 2025
Effect of mass drug administration on malaria incidence in southeast Senegal during 2020-22: a two-arm, open-label, cluster-randomised controlled trialEl-Hadji Konko Ciré Ba, Michelle E Roh, Abdoulaye Diallo, et al.
Medrxiv : the Preprint Server for Health Sciences|July 29, 2024
Mass drug administration to reduce malaria incidence in a low-to-moderate endemic setting: short-term impact results from a cluster randomised controlled trial in SenegalEl-Hadji Ba Konko Ciré, Michelle E Roh, Abdoulaye Diallo, et al.
Malaria Journal|December 10, 2014
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malariaNicholas J White, Elizabeth A Ashley, Judith Recht, et al.
Nature Communications|June 13, 2019
Author Correction: The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite densityHannah C Slater, Amanda Ross, Ingrid Felger, et al.
Lancet (London, England)|September 13, 2019
Malaria eradication within a generation: ambitious, achievable, and necessaryRichard G A Feachem, Ingrid Chen, Omar Akbari, et al.
Nature Communications|March 31, 2019
The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite densityHannah C Slater, Amanda Ross, Ingrid Felger, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Malaria Journal|December 8, 2021
Civilian-military malaria outbreak response in Thailand: an example of multi-stakeholder engagement for malaria eliminationMichelle E Roh, Kanyarat Lausatianragit, Nithinart Chaitaveep, et al.
Frontiers in Genetics|April 26, 2021
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical TrialsNuno Sepúlveda, Lynn Grignard, Jonathan Curry, et al.
Nucleic Acids Research|May 23, 2019
FLASH: a next-generation CRISPR diagnostic for multiplexed detection of antimicrobial resistance sequencesJenai Quan, Charles Langelier, Alison Kuchta, et al.
Lancet (London, England)|April 27, 2020
Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trialMichelle S Hsiang, Henry Ntuku, Kathryn W Roberts, et al.
The Lancet. Infectious Diseases|January 12, 2025
Effect of mass drug administration on malaria incidence in southeast Senegal during 2020-22: a two-arm, open-label, cluster-randomised controlled trialEl-Hadji Konko Ciré Ba, Michelle E Roh, Abdoulaye Diallo, et al.
Medrxiv : the Preprint Server for Health Sciences|July 29, 2024
Mass drug administration to reduce malaria incidence in a low-to-moderate endemic setting: short-term impact results from a cluster randomised controlled trial in SenegalEl-Hadji Ba Konko Ciré, Michelle E Roh, Abdoulaye Diallo, et al.
Malaria Journal|December 10, 2014
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malariaNicholas J White, Elizabeth A Ashley, Judith Recht, et al.
Nature Communications|June 13, 2019
Author Correction: The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite densityHannah C Slater, Amanda Ross, Ingrid Felger, et al.
Lancet (London, England)|September 13, 2019
Malaria eradication within a generation: ambitious, achievable, and necessaryRichard G A Feachem, Ingrid Chen, Omar Akbari, et al.
Nature Communications|March 31, 2019
The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite densityHannah C Slater, Amanda Ross, Ingrid Felger, et al.
Pageof 12